Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Rhob-as-a-suppressor-of-cancer-cell-growth-and-cell-transformation

 Low aromatics composition
The inventions claimed is: 1. A solvent composition comprising (a) a hydrocarbon component in an ...


 Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
The present invention describes a covalently-linked complex (CLC) for targeting a defined ...


 Compositions and methods for drug delivery using pH sensitive molecules
We claim: 1. A process for transfecting a nucleic acid into a cell in vivo, comprising: a) ...


 Chiral peptide nucleic acid monomers and oligomers
What is claimed is: 1. A peptide nucleic acid monomer having the formula: ##STR5## wherein: B is a ...


 Enzymatic DNA molecules
The present invention thus contemplates a synthetic or engineered (i.e., non-naturally-occurring) ...


 Multigene vectors
The present invention provides a method for preparing HSV vectors. The method comprises co-...


 Composition and method for inhibiting platelet aggregation
OF THE INVENTION This invention is provides a method of preventing or treating diseases or ...


 Nucleic acid probes
OF THE INVENTION "Derivatizable" nucleotides are nucleotides modified so as to include at the 4-...


 Assay for antiviral activity using complex of herpesvirus origin of replication and cellular protein
The drawings are first described. FIG. 1 is a diagram of the HSV-1 genome and oriS. FIG. 1A ...


 Substrate for detection of mammalian 5-C-DNA methyltransferase
OF THE INVENTION "Oligomeric DNA" or ODN, as used herein, means a DNA having from 10 to 75 "purine ...


 Rhob as a suppressor of cancer cell growth and cell transformation

Details
Inventors: Sebti, Said M.;
Assignee: University of South Florida Board of Trustees (Tampa, FL)
Primary Examiner: Nguyen; Dave Trong
Assistant Examiner: Marvich; Maria
Attorney, Agent or Firm: Saliwanchik, Lloyd & Saliwanchik

The protein RhoB and its variants as a supressor of cancer cell growth, inhibitor of malignant cell transformation, and modulator of oncogenic signaling, wherein introducing RhoB directly, or indirectly via a nucleic acid, into a malignantly transformed cell or a cancerous cell decreases phosphorylation of Erk and Akt proteins inhibiting the PI3-kinase/Akt cell survival pathway and promoting apoptotic cell death. Methods and compositions are disclosed for administering to cancer patients, a prophylactic treatment to minimize the risk of malignant transformation, and advantageous combination of RhoB therapy with existing cancer treatments. The protein RhoB and the variants of the present invention are prenylated with either geranylgeranyl or farnesyl, and provision is made for selection of the prenylating moiety.

DETAILED DESCRIPTION OF THE INVENTION In a general aspect, the present invention provides a method of inhibiting the growth of a cancerous cell, comprising contacting the interior of the cell with an effective amount of a RhoB protein or a variant thereof.
The formulations and methods of the present invention can be administered to treat a number of cancers, including but not limited to leukemias and lymphomas such as acute lymphocytic leukemia, acute nonlymphocytic leukemias, chronic lymphocytic leukemia, chronic myelogenous leukemia, Hodgkin's Disease, non-Hodgkin's lymphomas, and multiple myeloma, childhood solid tumors such as brain tumors, neuroblastoma, retinoblastoma, Wilms'Tumor, bone tumors, and soft-tissue sarcomas, common solid tumors of adults such as lung cancer, colon and rectum cancer, breast cancer, prostate cancer, urinary cancers, uterine cancers, oral cancers, pancreatic cancer, melanoma and other skin cancers, stomach cancer, ovarian cancer, brain tumors, liver cancer, laryngeal cancer, thyroid cancer, esophageal cancer, and testicular cancer.
The method of the present invention is particularly applicable in the treatment of pancreatic tumors and lung cancer.
The method of the present invention can be practiced on mammals, particularly humans.
The term "RhoB protein or a variant thereof" denotes RhoB-F, RhoB-GG and RhoB-WT proteins and any variants thereof that may be derived from RhoB-F, RhoB-GG or RhoB-WT as variants possessing at least one characteristic biological activity of RhoB, derived, for example, from the aforementioned proteins by truncation, oxidation, amino acid substitution, post-translational modification, labeling, or by linkage to another molecule.
In another embodiment, the invention provides a method of suppressing malignant transformation of a cell.
In this embodiment, RhoB or a variant thereof a composition comprising RhoB, a variant of RhoB, or a pharmaceutically acceptable salt thereof is administered to a cell capable of malignant transformation, thereby preventing transformation



Related patents
  Pharmacologically acceptable solvent vehicles
One aspect of the present invention is an antifungal composition that is suitable for parenteral administration to a mammal. The composition includes an amount of ...
  Aqueous fludarabine phosphate composition
OF THE INVENTION The present invention is based on the discovery that an aqueous fludarabine phosphate composition having enhanced stability at elevated temperatures ...
  Receptor-mediated gene delivery using bacteriophage vectors
In one aspect, the invention provides a method of gene delivery, comprising: contacting a mammalian cell with filamentous phage particles presenting a ligand on their ...
  Membrane-resident steroid receptors and methods of use thereof
This invention pertains to the discovery that DPR-1 (formerly known as END-2) a putative nuclear hormone receptor (NHR) that, based on gene reporter studies, is ...
  Process for integration of a chosen gene on the chromosome of a bacterium using Mu transposons
One aim of the invention is to describe a method for amplifying and stably fixing the copies of chosen genes in a microorganism with more flexibility and more ...
  Transposon-based transformation vectors
I claim: 1. A vector for inserting an exogenous gene into a chromosome of a eukaryotic cell, comprising: (a) a gene encoding a bacterial transposase; (b) two transposon ...
  Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and secondary screening capabilities
OF THE INVENTION Definitions Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary ...
  Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells
OF THE INVENTION Tc1 belongs to the Tc1/mariner superfamily of transposons found in nematodes, arthropods and chordates (Henikoff 1992; Raddice et al. 1994; Robertson 19...
  DNA-based transposon system for the introduction of nucleic acid into DNA of a cell
OF THE PREFERRED EMBODIMENTS The present invention relates to novel tranposases and the transposon that are used to introduce nucleic acid sequences into the DNA of a ...
  Methods for diagnosing sepsis
The present invention provides a pharmaceutical composition for treating conditions (diseases) mediated by the inflammatory cytokine cascade, comprising an effective ...

0.024

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved